The Latest on the Biopharmaceutical Industry’s Efforts to Beat Coronavirus

America’s biopharmaceutical companies are committed to developing solutions to help diagnose, treat and prevent COVID-19.  The biopharmaceutical industry is providing financial support and in-kind donations to organizations and collaborating with U.S. and global health authorities to combat this global public health emergency.

More than half of PhRMA members have R&D efforts under way or are providing donations of medicines and critical medical supplies as well as providing financial donations to support patients and first responders in addressing this evolving crisis.

Our Commitment to Beat Coronavirus

In these unprecedented times, we are coming together to achieve one shared goal: to beat COVID-19. The decades-long investments we have made in new technology, research and treatments have prepared us to act swiftly:
Small drop being dropped into test tube
We are rapidly screening our vast global libraries of medicines to identify potential treatments and have numerous clinical trials underway to test new and existing therapies.
Doctors walking down a well lit hallway
We are dedicating our top scientists and using our investments in new technologies to speed the development of safe and effective vaccines.
Doctor taking readings from instruments on a wall
We are sharing the learnings from clinical trials in real time with governments and other companies to advance the development of additional therapies.
Bottles of medicines in a manufacturing setting
We are expanding our unique manufacturing capabilities and sharing available capacity to ramp up production once a successful medicine or vaccine is developed.
Women wearing a mask crossing a crosswalk amongst others in masks
We are collaborating with government agencies, hospitals, doctors and others to donate supplies and medicines to help those affected around the world.
Computer open with stethoscope right along side
We are working with governments and insurers to ensure that when new treatments and vaccines are approved they will be available and affordable for patients.

We all have unique roles to play and are confident that together we will be successful. And we won't rest until we are.